Westfield Capital Management Co. LP lowered its position in Avantor, Inc. (NYSE:AVTR - Free Report) by 11.0% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 2,439,577 shares of the company's stock after selling 302,501 shares during the quarter. Westfield Capital Management Co. LP owned about 0.36% of Avantor worth $63,112,000 as of its most recent SEC filing.
Several other large investors also recently added to or reduced their stakes in the company. UniSuper Management Pty Ltd raised its holdings in Avantor by 97.9% during the 1st quarter. UniSuper Management Pty Ltd now owns 9,500 shares of the company's stock valued at $243,000 after acquiring an additional 4,700 shares during the period. Quadrature Capital Ltd raised its stake in shares of Avantor by 45.3% during the 1st quarter. Quadrature Capital Ltd now owns 18,265 shares of the company's stock valued at $467,000 after purchasing an additional 5,695 shares during the period. Mount Yale Investment Advisors LLC lifted its holdings in Avantor by 93.9% during the 1st quarter. Mount Yale Investment Advisors LLC now owns 18,722 shares of the company's stock worth $479,000 after purchasing an additional 9,066 shares in the last quarter. Paloma Partners Management Co bought a new position in Avantor in the 1st quarter worth about $219,000. Finally, Kennedy Capital Management LLC grew its holdings in Avantor by 50.9% during the 1st quarter. Kennedy Capital Management LLC now owns 79,483 shares of the company's stock valued at $2,032,000 after buying an additional 26,814 shares in the last quarter. Hedge funds and other institutional investors own 95.08% of the company's stock.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently issued reports on AVTR shares. Wells Fargo & Company lowered their price target on shares of Avantor from $30.00 to $28.00 and set an "overweight" rating on the stock in a report on Monday, October 28th. Morgan Stanley boosted their price target on shares of Avantor from $28.00 to $29.00 and gave the company an "overweight" rating in a research report on Monday, July 29th. Robert W. Baird lowered their price objective on Avantor from $27.00 to $26.00 and set an "outperform" rating on the stock in a research report on Monday, October 28th. Royal Bank of Canada reissued an "outperform" rating and set a $34.00 price objective on shares of Avantor in a research note on Thursday, September 26th. Finally, UBS Group decreased their target price on Avantor from $30.00 to $29.00 and set a "buy" rating on the stock in a research note on Tuesday, October 8th. Three research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $27.57.
View Our Latest Stock Analysis on AVTR
Avantor Trading Up 1.6 %
Shares of Avantor stock traded up $0.33 during trading on Monday, reaching $21.11. The company's stock had a trading volume of 8,711,981 shares, compared to its average volume of 6,511,732. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84. Avantor, Inc. has a 52-week low of $19.59 and a 52-week high of $28.00. The firm's 50-day moving average is $23.77 and its two-hundred day moving average is $23.82. The company has a market cap of $14.37 billion, a price-to-earnings ratio of 45.89, a PEG ratio of 2.52 and a beta of 1.35.
Insiders Place Their Bets
In other news, CAO Steven W. Eck sold 3,525 shares of the firm's stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $25.06, for a total value of $88,336.50. Following the transaction, the chief accounting officer now owns 29,544 shares in the company, valued at approximately $740,372.64. This trade represents a 10.66 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.30% of the stock is currently owned by insiders.
About Avantor
(
Free Report)
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Further Reading
Before you consider Avantor, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.
While Avantor currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
